Nucleosides and Nucleotides as Antitumor and Antiviral Agents - Image 1

£69.58

Springer Nucleosides and Nucleotides as Antitumor and Antiviral Agents

Name: Nucleosides and Nucleotides as Antitumor and Antiviral Agents
Brand: Springer
Price: 69.58 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 42 days • 42 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 42 days • 1 price levels

Days at Price

Price Analysis

Most common price: £70 (42 days, 100.0%)

Price range: £70 - £70

Price levels: 1 different prices over 42 days

Description

Due to the worldwide epidemic of acquired immunodeficiency syndrome (AIDS), the past ten years have witnessed a flurry of activity in the chemotherapy of viral diseases. Unprecedented scientific efforts have been made by scientists and clinicians to combat infections of human immunodeficiency virus (HIY), the causative agent. Looking back over the past ten years, we have made remarkable progress toward the treatment of the viral disease: isolation of HIV only two years after the identification of the disease, plus major strides in the areas of the molecular biology and virology of the retrovirus, etc. More remarkably, the discovery of the chemotherapeutic agent AZT (Retrovir) was made within two years after the isolation and identification of the virus, followed by unprecedented drug development efforts to culminate in the FDA approval of AZT in twenty-three months, which was a record-breaking time for approval of any drug for a major disease. The last six to seven years have particularly been an exciting and productive period for nucleoside chemists. Since the activity of AZI' was established in 1985, nucleoside chemists have had golden opportunities to discover additional anti-HIV nucleosipes, which are hoped to be less toxic and more effective than AZT, and the opportunity continues. As we all are aware, AZT possesses extremely potent anti-HIY activity, and no other nucleoside or non nucleoside has surpassed the potency of AZT in vitro.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0306445204
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 31 July 1993
Listed Since: 14 December 2006

Barcode

No barcode data available

Springer Nucleosides and Nucleotides as Antitumor and Antiviral Agents

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer - Human Immunodeficiency Virus Reverse Transcriptase

Acyclic, Carbocyclic and L-Nucleosides

Reverse Transcriptase Inhibitors in HIV/AIDS Therapy (Infectious Disease)

Acyclic, Carbocyclic and L-Nucleosides

HIV Chemotherapy: A Critical Review

Advances in Antiviral Drug Design (Volume 3)

Reverse Transcriptase Inhibitors in HIV/AIDS Therapy (Infectious Disease)

Springer Antiviral Chemotherapy 5 - Advances in Biology 458

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Chemistry of Nucleosides and Nucleotides: Volume 3

Princeton University Press - The Human Immunodeficiency Virus Book

Nucleoside Triphosphates and their Analogs: Chemistry, Biotechnology, and Biological Applications

The Retroviridae (The Viruses)

Enzymatic and Chemical Synthesis of Nucleic Acid Derivatives

Artificial Nucleases: 13 (Nucleic Acids and Molecular Biology, 13)

Artificial Nucleases: 13 (Nucleic Acids and Molecular Biology, 13)

Springer Catalytically Active Nucleic Acids: 170 - Science Book

Catalytically Active Nucleic Acids: 170 (Advances in Biochemical Engineering/Biotechnology, 170)

AIDS: Virus- or Drug Induced?: 5 (Contemporary Issues in Genetics and Evolution, 5)

Cancers in People with HIV and AIDS: Progress and Challenges

First Decade Of Safe & Effective Hiv Vaccines

Novel Chemotherapeutic Agents: Preactivation in the Treatment of Cancer and AIDS (Medical Intelligence Unit)

Retroviruses: Molecular Biology, Genomics and Pathogenesis